Working together: interactions between vaccine antigens and adjuvants.
The development of vaccines containing adjuvants has the potential to enhance antibody and cellular immune responses, broaden protective immunity against heterogeneous pathogen strains, enable antigen dose sparing, and facilitate efficacy in immunocompromised populations. Nevertheless, the structural interplay between antigen and adjuvant components is often not taken into account in the published literature. Interactions between antigen and adjuvant formulations should be well characterized to enable optimum vaccine stability and efficacy. This review focuses on the importance of characterizing antigen-adjuvant interactions by summarizing findings involving widely used adjuvant formulation platforms, such as aluminum salts, emulsions, lipid vesicles, and polymer-based particles. Emphasis is placed on the physicochemical basis of antigen-adjuvant associations and the appropriate analytical tools for their characterization, as well as discussing the effects of these interactions on vaccine potency.
IDRI, 1124 Columbia Street, Ste 400, Seattle, WA 98104, USA.
Christopher B
CB
Fox
IDRI, Seattle, WA USA.
Ryan M
RM
Kramer
IDRI, Seattle, WA USA.
Lucien
L
Barnes V
IDRI, Seattle, WA USA.
Quinton M
QM
Dowling
IDRI, Seattle, WA USA.
Thomas S
TS
Vedvick
physicochemical characterization; vaccine adjuvant; vaccine antigen